Issue - meetings
Low Value Medicines Consultation
Meeting: 05/10/2017 - Health & Adults Scrutiny Sub-Committee (Item 3)
3 Low Value Medicines Consultation PDF 77 KB
This paper summarises the consultation run by
NHS England (NHSE) and NHS Clinical Commissioners as part of a plan
to develop new guidance on prescribing. It is hoped this guidance
could help the NHS save money, while continuing to deliver the best
possible outcomes for patients. There is an NHSE requirement that
the consultation is discussed at the local overview and scrutiny
committee.
Additional documents:
- HS Low value medicines consultation discussion paper September 2017.docx, item 3 PDF 271 KB
- HS_LVM Consultation_Appendix 1_Monitoring Document PrescQIPP_12m to June 2017.pdf, item 3 PDF 310 KB
- Copy of HS_LVM Consultation_Appendix 2_graphs_Jan-Dec16_20170719_per_1000pts_subs sorted for TH Aug 2017.xlsx, item 3 PDF 22 KB
Minutes:
This paper summarises the consultation run by NHS England (NHSE) and NHS Clinical Commissioners as part of a plan to develop new guidance on prescribing. It is hoped this guidance could help the NHS save money, while continuing to deliver the best possible outcomes for patients. There is an NHSE requirement that the consultation is discussed at the local overview and scrutiny committee.
The new guidance could mean items that are often routinely prescribed could only be provided where they are absolutely necessary and deemed to be ‘clinically effective’ with the aim to produce a clear and equal prescribing process across the country and make savings which would be reinvested in patient care.
A list of 18 items considered to be low priority for NHS funding has been produced as part of the consultation. This list, along with full details of the consultation, is available on the NHS England website. In addition the consultation is asking for views on the routine prescribing of some over the counter (OTC) medicines used for minor ailments or self-limiting illness. The consultation is open until 21 October 2017.
It was noted that Tower Hamlets Clinical Commissioning Group (THCCG) has:
I. full year costs of £636,172 on the affected items but this would not be realised as a potential saving as patients may require alternative medicines to be prescribed;
II. prescribing which falls within the TOP 50% of CCGs for 7 of the 18 items being covered by the consultation;
III. prescribing guidance in place already managing the costs of some of the affected items which is already and continuing to reduce the prescribing of these medicines; and
IV. not undertaken any work on proposals or guidance to reduce the routine prescribing of over the counter (OTC) medicines used for minor ailments or self-limiting illness.
The questions and comments from Members on the report may be summarised as follows:
The Sub-Committee:
· Noted the list of 18 items considered to be low priority for NHS funding and why are they actually available on prescription. However, the Sub-Committee queried that if somebody was only able to get such specific medication on prescription what would be the impact on LBTH;
· Noted those implications would need to be mapped as part of a wider look of the impact in the changes; and
· Asked that more should be done to encourage people to move towards self-care/management of certain medicines or accessing their medical needs via a Local Pharmacy rather than a General Practitioner’s Surgery.
Accordingly, the Chair Moved and it was:-
RESOLVED
To:
|
||
|
|
|